On May 26, 2023, Linus Biotechnology Inc closed the transaction. The transaction include participation from new investor Y.A.,C. Holdings Co., Ltd, returning investors Bow Capital and David Bellet family office. The transaction included participation from 3 investors pursuant to exemption provided under Regulation D.